2024 Global Immunohematology and NAT Screening: US, Europe, Japan--Transfusion Medicine Analyzers and Reagents--Supplier Shares and Strategies, Technology and Instrumentation Review, Emerging Opportunities
This new seven-country strategic analysis was prepared by VPGMarketResearch in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. RationaleDuring the next five years, the global blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology.The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.Strategic Recommendations%li%New product development opportunities with significant market appeal.%li%Alternative market penetration strategies.%li%Potential market entry barriers and risks.Worldwide Market Overview
France, Germany, Italy, Japan, Spain, UK, USA
The report explores future marketing and technological trends in the US, Europe and Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).Infectious Disease Screening TestsAIDS (HIV NAT, HIV-1/2), Cytomegalovirus,Hepatitis (HAV NAT, HBV NAT, HBs Ag, ; Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.Sales and Market Share AnalysisSales and market share estimates of leadingsuppliers of blood banking of reagentsand instruments, by country and individualproduct.Competitive AssessmentsStrategic assessments of major suppliers and emerging market entrants, including their sales,product portfolios, marketing tactics, and newproducts in R&D.Market Segmentation Analysis%li%Comprehensive market segmentationanalysis, including review of the marketdynamics, trends, structure, size, growth,and key suppliers by country.%li%Test volume and sales forecasts for over 40 blood banking tests, including NAT, by country and market segment:%li%Blood Centers%li%Plasma Fractionation Facilities%li%Hospitals%li%Commercial/Private Laboratories%li%Military Blood BanksCurrent and Emerging Products%li%Analysis of current and emerging blood banking tests.%li%Review of automated and semi-automatedanalyzers, including their operatingcharacteristics, features, and selling prices.Technology Review%li%Assessment of current and emergingtechnologies, and their potential applicationsfor the blood banking market.%li%Comprehensive lists of companies developingor marketing new technologies and products by test.
Contains 775 pages and 227 tables
- Estimates of facilities performing blood banking tests, by country.%li%Test volume and sales projections by country.
France, Germany, Italy, Japan, Spain, UK, USA
The report explores future marketing and technological trends in the US, Europe and Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).Infectious Disease Screening TestsAIDS (HIV NAT, HIV-1/2), Cytomegalovirus,Hepatitis (HAV NAT, HBV NAT, HBs Ag, ; Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.Sales and Market Share AnalysisSales and market share estimates of leadingsuppliers of blood banking of reagentsand instruments, by country and individualproduct.Competitive AssessmentsStrategic assessments of major suppliers and emerging market entrants, including their sales,product portfolios, marketing tactics, and newproducts in R&D.Market Segmentation Analysis%li%Comprehensive market segmentationanalysis, including review of the marketdynamics, trends, structure, size, growth,and key suppliers by country.%li%Test volume and sales forecasts for over 40 blood banking tests, including NAT, by country and market segment:%li%Blood Centers%li%Plasma Fractionation Facilities%li%Hospitals%li%Commercial/Private Laboratories%li%Military Blood BanksCurrent and Emerging Products%li%Analysis of current and emerging blood banking tests.%li%Review of automated and semi-automatedanalyzers, including their operatingcharacteristics, features, and selling prices.Technology Review%li%Assessment of current and emergingtechnologies, and their potential applicationsfor the blood banking market.%li%Comprehensive lists of companies developingor marketing new technologies and products by test.
Contains 775 pages and 227 tables
I. Introduction
II. Worldwide Market Overview
1. BUSINESS ENVIRONMENT
2. MARKET STRUCTURE
3. MARKET SIZE AND GROWTH
III. Major Product Development Opportunities
A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
VI. Worldwide Technology and Market Overview
A. Major Blood Typing, Grouping and Infectious
Disease Screening Tests
1. BLOOD TYPING AND GROUPING TESTS
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
Table of Contents (continues)
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. INFECTIOUS DISEASE SCREENING TESTS
a. AIDS/HIV
- Background
- Diagnostic Tests
° Enzyme Immunoassay
° Viral Load/Drug Resistance Testing
° Genotype and Phenotype Testing
- Blood Banking Considerations
b. Hepatitis Markers
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D (Delta Hepatitis)
- Hepatitis E
- Hepatitis G
- Vaccines and Drugs
c. Cytomegalovirus
- Background
- Diagnostic Tests
- Vaccines and Drugs
d. Syphilis
- Background
- Diagnostic Tests
- Vaccines and Drugs
e. West Nile Virus
- Background
- Clinical Syndromes
- Diagnostic Tests
- Vaccines and Drugs
f. Parvovirus B19
- Microbiology
- Epidemiology
- Clinical Syndromes
- Diagnostic Test
- Vaccines and Drugs
II. Worldwide Market Overview
1. BUSINESS ENVIRONMENT
2. MARKET STRUCTURE
3. MARKET SIZE AND GROWTH
III. Major Product Development Opportunities
A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
VI. Worldwide Technology and Market Overview
A. Major Blood Typing, Grouping and Infectious
Disease Screening Tests
1. BLOOD TYPING AND GROUPING TESTS
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
Table of Contents (continues)
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. INFECTIOUS DISEASE SCREENING TESTS
a. AIDS/HIV
- Background
- Diagnostic Tests
° Enzyme Immunoassay
° Viral Load/Drug Resistance Testing
° Genotype and Phenotype Testing
- Blood Banking Considerations
b. Hepatitis Markers
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D (Delta Hepatitis)
- Hepatitis E
- Hepatitis G
- Vaccines and Drugs
c. Cytomegalovirus
- Background
- Diagnostic Tests
- Vaccines and Drugs
d. Syphilis
- Background
- Diagnostic Tests
- Vaccines and Drugs
e. West Nile Virus
- Background
- Clinical Syndromes
- Diagnostic Tests
- Vaccines and Drugs
f. Parvovirus B19
- Microbiology
- Epidemiology
- Clinical Syndromes
- Diagnostic Test
- Vaccines and Drugs
